Charles River Laboratories’ Post

SAVE THE DATE for June 26th (note date change from June 19) at 11am ET for our next RIM Intelligent Automation Team meeting. Topics and DIA member meeting link below. Many pharmaceutical and biotech organizations are evaluating or executing and implementing meaningful use cases of AI-driven automation to streamline regulatory information management. But, how is adoption by users and key stakeholders looking? Wim DHaeze, PhD, ELS, RIMS/DMS Lead with Sarepta Therapeutics, will moderate a discussion around adoption of AI-driven automation in RIMS. Some questions and topics will be shared prior to the meeting; active participation during the discussion is expected so we can learn from each other’s approaches. DIA member meeting link: https://lnkd.in/eE25Qyvd #ai #changemanagement #regulatory #rim #diarim

We know that every moment makes a difference in the lives of patients and their families. That’s why Charles River’s #Apollo’s™ ability to provide real-time access to study data gives you the opportunity to make quick decisions, accelerating your time to market so your therapies can get to the people who need them. Explore Apollo™ for Safety Assessment: https://okt.to/srqU3m

At Charles River, we understand the urgency in getting life-changing therapies to patients and their families. That's why our #Apollo™ platform provides real-time access to study data, empowering you to make quicker decisions and accelerate your time to market. With Apollo, you can Gain immediate insights into your research progress. Make data-driven decisions faster and get your therapies to those in need sooner. check it out👇

When picking an eCOA for your next trial, you need a trusted partner. Learn how IQVIA eCOA is the best eCOA for your next trial: https://bit.ly/3xRvUsH #eCOA #ClinicalTrials

Sensome signs distribution deal for clot-sensing guidewire in Japan Sensome has signed an exclusive distribution agreement with Cosmotec, a company within the M3 Group, for its clot-sensing guidewire in Japan. The post Sensome signs distribution deal for clot-sensing guidewire in Japan appeared first on Medical Devi... https://lnkd.in/eJi5c8ei #BioTech #science

Join this panel of experts from Roche, Pfizer, Alexion Pharmaceuticals, Inc., and Certara to discuss leveraging today’s technology for accelerated submission success. During the Nov. 29 webinar, in partnership with Regulatory Affairs Professionals Society (RAPS), we’ll share real-life examples and lessons learned. https://ow.ly/FKRs50Q4MUh #Pharma #RegulatoryAffairs

Join Certara & RAPS on November 29 for a joint webinar to understand how today’s technologies can be leveraged to accelerate submission preparation. Register at https://ow.ly/FKRs50Q4MUh #Pharma #RegulatoryAffairs

Learn more about the highlights of #AUTOMAhealth2023 💊

Join the Certara Synchrogenix team as they discuss the use of technology to accelerate your regulatory submissions. #regulatory #regulatorysubmissions